1.Management Strategy for Congenital Choledochal Cyst with Co-existing Intrahepatic Dilation and Aberrant Bile Duct As Well As Other Complicated Biliary Anomalies.
Qian DONG ; Buxian JIANG ; Hong ZHANG ; Zhong JIANG ; Hongting LU ; Chuanmin YANG ; Yu CHENG ; Xiwei HAO
Yonsei Medical Journal 2006;47(6):826-832
The purpose of this study was to investigate and discuss imaging methods and management strategies for congenital choledochal cyst with co-existing intrahepatic dilation and aberrant bile duct as well as other complicated biliary anomalies. In this study we reviewed and analyzed 72 patients with congenital choledochal cyst, ranging in age from 15 days to 12 years old and who were seen at our hospital during the past 12 years, from January 1993 to October 2005. The image manifestation and clinical significance of patients with co- xisting intrahepatic biliary dilation and aberrant bile duct were carefully examined during operation via MRCP, cholangiography and choledochoscope. Twenty-two cases (30.1%) presented with intrahepatic bile duct dilation and 12 of these were of the cystic type. That is, the orifice of the dilated intrahepatic tract that converged into the common hepatic duct showed membrane or septum-like stenosis. In 10 cases the dilation tapered off from the porta hepatis to the initiating terminals of the intra-hepatic bile ducts and was not accompanied by stenosis. An aberrant bile duct was observed in 2 of the cases. In 3 cases, the right and left hepatic ducts converged at the choledochal cyst. In conclusion, the imaging methods for intrahepatic bile duct dilation possess important clinical significance. Further, for hepatojejunostomy with radical excision of a choledochal cyst, additional operative procedures for intrahepatic stenosis, possible bile duct malformation and pancreaticobiliary common duct calculi can potentially reduce postoperative complications.
Tomography, X-Ray Computed
;
Postoperative Complications/ultrasonography
;
Male
;
Liver Diseases/complications/*radiography/surgery
;
Infant, Newborn
;
Infant
;
Humans
;
Female
;
Choledochal Cyst/complications/*radiography/surgery
;
Cholangiography
;
Child, Preschool
;
Child
;
Bile Ducts/*abnormalities/pathology/surgery
2.Management Strategy for Congenital Choledochal Cyst with Co-existing Intrahepatic Dilation and Aberrant Bile Duct As Well As Other Complicated Biliary Anomalies.
Qian DONG ; Buxian JIANG ; Hong ZHANG ; Zhong JIANG ; Hongting LU ; Chuanmin YANG ; Yu CHENG ; Xiwei HAO
Yonsei Medical Journal 2006;47(6):826-832
The purpose of this study was to investigate and discuss imaging methods and management strategies for congenital choledochal cyst with co-existing intrahepatic dilation and aberrant bile duct as well as other complicated biliary anomalies. In this study we reviewed and analyzed 72 patients with congenital choledochal cyst, ranging in age from 15 days to 12 years old and who were seen at our hospital during the past 12 years, from January 1993 to October 2005. The image manifestation and clinical significance of patients with co- xisting intrahepatic biliary dilation and aberrant bile duct were carefully examined during operation via MRCP, cholangiography and choledochoscope. Twenty-two cases (30.1%) presented with intrahepatic bile duct dilation and 12 of these were of the cystic type. That is, the orifice of the dilated intrahepatic tract that converged into the common hepatic duct showed membrane or septum-like stenosis. In 10 cases the dilation tapered off from the porta hepatis to the initiating terminals of the intra-hepatic bile ducts and was not accompanied by stenosis. An aberrant bile duct was observed in 2 of the cases. In 3 cases, the right and left hepatic ducts converged at the choledochal cyst. In conclusion, the imaging methods for intrahepatic bile duct dilation possess important clinical significance. Further, for hepatojejunostomy with radical excision of a choledochal cyst, additional operative procedures for intrahepatic stenosis, possible bile duct malformation and pancreaticobiliary common duct calculi can potentially reduce postoperative complications.
Tomography, X-Ray Computed
;
Postoperative Complications/ultrasonography
;
Male
;
Liver Diseases/complications/*radiography/surgery
;
Infant, Newborn
;
Infant
;
Humans
;
Female
;
Choledochal Cyst/complications/*radiography/surgery
;
Cholangiography
;
Child, Preschool
;
Child
;
Bile Ducts/*abnormalities/pathology/surgery
3.Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation.
Ji Hye JUN ; Jong Ho CHOI ; Si Hyun BAE ; Seh Hoon OH ; Gi Jin KIM
Clinical and Molecular Hepatology 2016;22(3):372-381
BACKGROUND/AIMS: Chronic liver disease leads to liver fibrosis, and although the liver does have a certain regenerative capacity, this disease is associated with dysfunction of the liver vessels. C-reactive protein (CRP) is produced in the liver and circulated from there for metabolism. CRP was recently shown to inhibit angiogenesis by inducing endothelial cell dysfunction. The objective of this study was to determine the effect of CRP levels on angiogenesis in a rat model of liver dysfunction induced by bile duct ligation (BDL). METHODS: The diameter of the hepatic vein was analyzed in rat liver tissues using hematoxylin and eosin (H&E) staining. The expression levels of angiogenic factors, albumin, and CRP were analyzed by real-time PCR and Western blotting. A tube formation assay was performed to confirm the effect of CRP on angiogenesis in human umbilical vein endothelial cells (HUVECs) treated with lithocholic acid (LCA) and siRNA-CRP. RESULTS: The diameter of the hepatic portal vein increased significantly with the progression of cirrhosis. The expression levels of angiogenic factors were increased in the cirrhotic liver. In contrast, the expression levels of albumin and CRP were significantly lower in the liver tissue obtained from the BDL rat model than in the normal liver. The CRP level was correlated with the expression of albumin in hepatocytes treated with LCA and siRNA-CRP. Tube formation was significantly decreased in HUVECs when they were treated with LCA or a combination of LCA and siRNA-CRP. CONCLUSION: CRP seems to be involved in the abnormal formation of vessels in hepatic disease, and so it could be a useful diagnostic marker for hepatic disease.
Angiogenic Proteins/genetics/metabolism
;
Animals
;
Bile Ducts/surgery
;
C-Reactive Protein/*analysis/genetics/metabolism
;
Cells, Cultured
;
Disease Models, Animal
;
Hepatic Veins/abnormalities
;
Hepatocytes/cytology/metabolism
;
Human Umbilical Vein Endothelial Cells
;
Humans
;
Lithocholic Acid/pharmacology
;
Liver/metabolism/pathology
;
Liver Cirrhosis/etiology
;
Liver Diseases/metabolism/*pathology
;
Male
;
Microscopy, Fluorescence
;
Mitochondria/drug effects/metabolism
;
RNA Interference
;
RNA, Small Interfering/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Real-Time Polymerase Chain Reaction
;
Serum Albumin/genetics/metabolism